Dr. Suleman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Cambridge
Kansas City, KS 66160Fax+1 816-331-4325
Education & Training
Ross University School of MedicineClass of 2015
University of Missouri-Kansas CityPharmD, Pharmacy, 1999 - 2004
Certifications & Licensure
KS State Medical License 2019 - 2025
CT State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 4 citationsTiming of Toxicities and Non-Relapse Mortality Following CAR T Therapy in Myeloma.William Wesson, Danai Dima, Nahid Suleman, Md Saiful Islam Saif, Carine Tabak
Transplantation and Cellular Therapy. 2024-09-01 - 1 citationsManaging Infection Complications in the Setting of Chimeric Antigen Receptor T cell (CAR-T) Therapy.Nausheen Ahmed, Olalekan Oluwole, Zahra Mahmoudjafari, Nahid Suleman, Joseph P McGuirk
Clinical Hematology International. 2024-01-01 - Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review.Polina Bellman, Jesus D Gonzalez-Lugo, Moazzam Shahzad, Muhammad Kashif Amin, Muhammad Fareed Khalid
Frontiers in Oncology. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
